RecruitingNot applicableNCT05408715
A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
Studying Spondyloepiphyseal dysplasia congenita
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Innoskel
- Principal Investigator
- Andrea Superti-FurgaCentre hospitalier universitaire vaudois, Lausanne
- Intervention
- Natural History Study(other)
- Enrollment
- 60 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2022 – 2026
Study locations (2)
- Hopital Necker-Enfants Malades, Paris, France
- Hospital Universitario La Paz, Madrid, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05408715 on ClinicalTrials.gov